MedTrace Logo

3D Printed Custom Applicators for HDR BT (DISCO)

NCT06432478 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-02-06

No results posted yet for this study

Summary

Intracavitary brachytherapy for gynaecological cancer currently use cylinder-type applicators or custom wax moulds to place a radioactive source in close proximity to the treatment area and provide highly conformal dose distributions. This study is a Phase IIa non-randomised interventional pilot trial that will investigate the feasibility of successfully treating patients with 3D-printed custom applicators.

Conditions

Interventions

DEVICE

3D-printed custom applicator

3D-printed custom applicator

Sponsors & Collaborators

  • Northern Sydney and Central Coast Area Health Service

    collaborator OTHER

  • Royal North Shore Hospital

    lead OTHER

Principal Investigators

  • Marita Morgia, MD · Royal North Shore Hospital

  • Jeremy Booth, PhD QMP · Royal North Shore Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-24
Primary Completion
2028-09-30
Completion
2028-09-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06432478 on ClinicalTrials.gov